Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2013
12/05/2013US20130324457 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
12/05/2013US20130319950 Selective oxoanion separation using a tripodal ligand
12/05/2013CA2874938A1 Heterocycles capable of modulating t-cell responses, and methods of using same
12/04/2013EP2669282A1 Tetrazoyloxime derivative and plant disease control agent
12/04/2013EP2669281A1 Method for producing di(arylamino)aryl compound, and synthetic intermediate therefor
12/04/2013EP2669272A1 Indole derivative and pharmacologically acceptable salt of same
12/04/2013EP2669271A1 Indole derivative, and pharmacologically acceptable salt thereof
12/04/2013EP2669270A1 Ring-fused compound
12/04/2013EP2668179A1 New 5-alkynyl-pyridines
12/04/2013EP2668178A1 New 5-alkynyl-pyridines
12/04/2013EP2668177A1 Substituted pyridinyl-pyrimidines and their use as medicaments
12/04/2013EP2668168A1 COMPOUNDS FOR THE REDUCTION OF ß-AMYLOID PRODUCTION
12/04/2013EP2668167A1 Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/04/2013EP2668165A1 Novel tetrahydroquinoline derivatives
12/04/2013EP2668162A1 Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
12/04/2013EP2668157A1 Protease activated receptor 2 (par2) antagonists
12/04/2013EP2668155A2 New aryl-benzocycloalkyl amide derivatives
12/04/2013EP2667870A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/04/2013CN1989106B N-羟基酰胺衍生物及其应用 N- hydroxyamide derivatives and their Applications
12/04/2013CN103429586A Piperazinedione compounds
12/04/2013CN103429585A Indazolyl triazole derivatives as irak inhibitors
12/04/2013CN103429584A Quinoline derivatives as fungicides
12/04/2013CN103429583A Triazole derivatives as WNT signaling pathway inhibitors
12/04/2013CN103429582A MST1 kinase inhibitors and method of use thereof
12/04/2013CN103429572A Tetrasubstituted cyclohexyl compounds as kinase inhibitors
12/04/2013CN103429571A Substituted pyridines as sodium channel blockers
12/04/2013CN103429569A New azaspirodecanone compounds
12/04/2013CN103429567A Process for preparing chiral amino acids
12/04/2013CN103420991A Pyrrolidine derivative used as hepatitis c inhibitor and application thereof in medicine
12/04/2013CN103420988A Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/04/2013CN103420987A Pyridine derivatives and preparation methods thereof
12/04/2013CN103420986A Compound replacing quinoidines as well as using method and application of compound
12/04/2013CN103420985A Dabigatran derivative used as prodrug, and preparation method and application thereof
12/04/2013CN103420984A Dabigatran derivative used as prodrug, and preparation method and application thereof
12/04/2013CN103420983A Dabigatran derivative, and preparation method and application thereof
12/04/2013CN103420982A Dabigatran derivative, and preparation method and application thereof
12/04/2013CN103420981A Substituted-pyrrolidinyl-contained thiomorpholine compounds
12/04/2013CN103420980A Dabigatran derivatives
12/04/2013CN103420979A Esomeprazole sodium refining method
12/04/2013CN103420978A Preparation method of magnesium salt of benzimidazole compound
12/04/2013CN103420977A Acetylene derivative with anti-tumor activity
12/04/2013CN103420976A Method for preparing imatinib and mesylate
12/04/2013CN103420975A Fluorine-contained o-amino thiobenzamide type compound and application thereof
12/04/2013CN103420940A Aralkyl naphthenic aminopiperazine derivatives and applications thereof as multi-targeted antidepressant
12/04/2013CN103420917A Benzamide compounds containing fused ring structure and applications thereof as antitumor medicaments
12/04/2013CN103420910A Electron-transport blue luminescent material and use thereof
12/04/2013CN103420906A Novel tyrosine protein kinase inhibitor
12/04/2013CN103420898A Diaryl piperidine derivatives and applications thereof as multiple-target-point antidepressants
12/04/2013CN103420894A 2- butane-1,4-diketone compounds, preparation method and applications
12/04/2013CN103417532A Sesquiterpene lactone compound and uses of derivative thereof in preparation of drugs
12/04/2013CN102643654B Liquid crystal photo-alignment material and application thereof
12/04/2013CN102066343B Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators
12/04/2013CN101775005B Cadrofloxacin hydrochloride-I crystal and preparation method thereof
12/04/2013CN101622243B Sulfonamide derivative
12/04/2013CN101460476B Organic compounds
12/03/2013US8598364 Oligomer-protease inhibitor conjugates
12/03/2013US8598362 Methods for the preparation of charged crosslinkers
12/03/2013US8598360 Apoptosis signal-regulating kinase inhibitors
12/03/2013US8598353 Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors
12/03/2013US8598349 Method for manufacturing conjugated aromatic compound
12/03/2013US8598345 Substituted heteroarylamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same
12/03/2013US8598217 Imidazole derivatives and their use as modulators of cyclin dependent kinases
12/03/2013US8598212 Therapeutic agent and preventative agent for alzheimer's disease
12/03/2013US8598211 Carboxamide compounds and their use as calpain inhibitors IV
12/03/2013US8598208 Pyridine derivatives as S1P1/EDG1 receptor modulators
12/03/2013US8598201 Polymorphs of 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride
12/03/2013US8598189 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
12/03/2013US8598181 Modulators of ATP-binding cassette transporters
12/03/2013US8598179 Pyrazole-carboxamide derivatives as P2Y12 antagonists
12/03/2013US8598176 Pyridazine compound and use thereof
12/03/2013US8598171 Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders
12/03/2013US8598169 Biaryl compositions and methods for modulating a kinase cascade
12/03/2013US8598159 Therapeutic pyrazoloquinoline derivatives
12/03/2013US8598157 5-alkynyl-pyridines
12/03/2013US8597799 Organosulfur compound, process for producing the same, and organic electroluminescence element using the same
12/03/2013CA2658327C Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses
12/03/2013CA2615049C Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
12/03/2013CA2570987C Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
12/03/2013CA2516660C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/2013
11/28/2013WO2013177168A1 Pyrimidine compounds for the treatment of cancer
11/28/2013WO2013176402A1 Indole compound, compound for organic electric element containing derivative thereof, organic electric element using same, and corresponding electronic device
11/28/2013WO2013176194A1 Organic electroluminescent element, organic electroluminescent lighting device, and organic electroluminescent display device
11/28/2013WO2013175415A1 Substituted pyrimidine compounds and uses thereof
11/28/2013WO2013175388A1 Novel ring-substituted n-pyridinyl amides as kinase inhibitors
11/28/2013WO2013175215A1 Triazoles as kv3 inhibitors
11/28/2013WO2013175211A1 Hydantoin derivatives as kv3 inhibitors
11/28/2013WO2013174937A1 Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases
11/28/2013WO2013174895A1 Heterocyclyl pyrimidine analogues as tyk2 inhibitors
11/28/2013WO2013174843A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxylic thioamides and use thereof as herbicides
11/28/2013WO2013174780A1 Substituted dipyridylamines and uses thereof
11/28/2013WO2013174757A1 Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof
11/28/2013US20130317227 Process for making a solid-state form of amg 706
11/28/2013US20130317223 Slow Release of Organoboronic Acids in Cross-Coupling Reactions
11/28/2013US20130317221 3-arylethynyl substituted quinazolinone compounds
11/28/2013US20130317216 2,4-pyrimidinediamine compounds and their uses
11/28/2013US20130317213 Hepatitis C Virus Inhibitors
11/28/2013US20130317065 Indole derivative and pharmacologically acceptable salt thereof
11/28/2013US20130317057 Aldosterone synthase inhibitors
11/28/2013US20130317041 Compounds
11/28/2013US20130317031 Nuclear Transport Modulators And Uses Thereof
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 1080